Home About Us Contact Us
All CoursesCourses by TopicCourses by SpecialtyCourses by Specialty CreditRegister Now!!
Register Now!!
Member Login
Your Account
Your Test History
Your Certificates
Your Payment History
All Courses
Courses by Topic
Courses by Specialty
Courses by Specialty Credit
State Requirements
Home : Advanced Search : Course view

Internal Medicine Alert (Vol. 41, No. 17) - September 15, 2019

Specialty: Internal Medicine Format: Text 
Course #: 14664  Price: $42.00  
Release date: 2019-09-09  Valid through: 2022-09-15  
Publication: This activity appeared in Internal Medicine Alert, published on 2019-09-15. 
Review date: 2019-09-09 
Course viewing requirements  (opens in a new window)
Instructions for Course Participation  (opens in a new window)
Legal disclaimer  (opens in a new window)

Learning Objectives

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe the advantages, disadvantages, and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • Identify cost-effective treatment regimens
  • Explain the advantages and disadvantages of new disease screening procedures

Accreditation Statement

Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Relias LLC designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This Enduring Material activity, Internal Medicine Alert, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins 1/15/2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Approved for 2 AAFP Prescribed credits.

The American Osteopathic Association has approved this continuing education activity for up to 2 AOA Category 2-B credits.

Financial Disclosure

Internal Medicine Alert’s Physician Editor Stephen Brunton, MD, is a retained consultant for Abbott, Acadia, Allergan, AstraZeneca, Avadel, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Mylan, and Salix; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, and Novo Nordisk. Peer Reviewer Gerald Roberts, MD; Editor Jonathan Springston; Editor Jason Schneider; Editorial Group Manager Leslie Coplin; and Accreditations Manager Amy M. Johnson, MSN, RN, CPN, report no financial relationships relevant to this field of study.

You are not currently logged in.
  • To view content articles and access course testing and evaluation, please login or register now


For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com.